- Order Reprints
- Print Article
CVS Health beat analysts’ first-quarter earnings and revenue estimates but lowered guidance for the full year. The stock was falling in premarket trading Wednesday.
Summary
Summary
U.S
Europe
Asia
FX
Rates
Futures
ETFs
Crypto
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
https://www.barrons.com/articles/cvs-stock-earnings-d710e318
Related posts:
Why Plug Power Stock Is Skyrocketing Today
2 Safe Dividend Stocks Yielding at Least 6%; Analysts Say ‘Buy’
Nevada lithium mine gets conditional $700M government loan
Bill Gates falls another notch on the world’s billionaire list, as AI takes Larry Ellison higher
Intel Stock Will Plunge Further, Analyst Says, After ‘Worst’ Quarter He Has Ever Seen